AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 272 min read$HCA

HCA Healthcare Inc (HCA) Q3 2026 Earnings Call Highlights: 22 Straight Quarters

HCA Healthcare (HCA) reported Q3 2026 earnings, highlighting a 19% decline in exchange equivalent admissions, a $400M unfavorable EBITDA impact, and reduced elective surgical volumes. The company expects $550M-$650M less in Medicaid supplemental payments in 2027. HCA anticipates 2027 earnings to be generally consistent with 2026, citing exchange headwinds and reduced supplemental payments.

Original reporting
finance.yahoo.com
Published Oct 27, 2026, 9:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 9:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
HCA Healthcare Inc (HCA) Q3 2026 Earnings Call Highlights: 22 Straight Quarters — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$HCABearishMed
01

Why it matters

The guidance signals flat earnings growth and heightened cost pressures, likely prompting a negative market reaction.

02

Market read

The new guidance and operational metrics provide fresh material that could move HCA's stock in the near term.

03

What to watch

Potential upside from the proposed 340B regulation and continued growth in commercial revenue may mitigate some headwinds.

Relevance 7/10Novelty 7/10Timing: post‑earnings call today

Background

HCA Healthcare provided its Q3 2026 earnings call highlights, focusing on admission declines, Medicaid payment reductions, and guidance for 2027.

Company-level read

Ticker impact

$HCABearishHigh confidence
Context

Earnings call disclosed a 19% YoY decline in admissions and $550‑$650 M reduction in Medicaid supplemental payments for 2027, indicating flat growth and pressure on earnings.

Expected impact

downward pressure as investors price in reduced Medicaid payments and exchange volume declines

Evidence & confidence

The disclosed quantitative guidance is new and material, affecting revenue and profit outlook.

Market effects

Sector

Hospital and health‑care services sector may see broader concerns over Medicaid payment trends and exchange enrollment impacts.

Regional

U.S. healthcare stocks could experience modest weakness as the guidance highlights systemic reimbursement pressures.

Global

Limited; the news is primarily U.S. focused with minimal immediate global spillover.

Counterpoint

What could challenge this read

If the company successfully executes its resiliency program, earnings could exceed flat guidance, offering a buying opportunity on dip.

Key entities

  • Executive
    Mike Marks

    Chief Financial Officer who detailed the Medicaid payment reduction and exchange headwinds.

  • Executive
    Sam Hazen

    Chief Executive Officer who discussed overall outlook and strategic positioning.

Read at source← All news

StoryHCA Healthcare posts Q3 beat, cites $400 M uninsured hit and lifts full‑year outlook

Also covered by

4 outlets

Related articles

OCT 28
$HCAMed

BofA raises HCA Healthcare stock price target on solid execution

BofA Securities raised its price target on HCA Healthcare (NYSE:HCA) to $500 from $450, citing solid execution and upside from supplemental Medicaid programs. The company's Q3 EBITDA exceeded estimates, with revenue of $19.85B and EPS of $7.22. HCA maintained its guidance range but faces near-term headwinds. The stock trades at an EV/EBITDA of 9.6x and a P/E ratio of 14.85.

investing.com2 min
OCT 27
$HCAMedAI 8/10

What HCA Healthcare (HCA) Said on Its Q3 Earnings Call

HCA Healthcare reported $50M in incremental Medicaid benefits in Q3, raising its 2026 estimate to $600M-$800M. Costs were flat, but professional fees rose 12%. HCA reaffirmed 2026 guidance, expecting upper-half results. For 2027, it anticipates strong demand and earnings similar to 2026. The company spent $1.36B on capital expenditures, repurchased $3B in shares, and paid $165M in dividends.

finance.yahoo.com2 min
OCT 27
$HCAHighAI 9/10

HCA (HCA) Q3 2026 Earnings Call Transcript

HCA Healthcare reported Q3 2026 revenue of $19.849 billion, up 3.6% YoY, with net income of $1.579 billion. EPS grew 4.4% to $7.27. Adjusted EBITDA rose 1.2% to $3.918 billion. Volume growth continued, but payer mix shifts impacted earnings. The company raised full-year revenue and EBITDA guidance. Management expects stable 2027 earnings despite Medicaid payment headwinds.

fool.com2 min
OCT 27
$HCAHighAI 8/10

HCA signals flat 2027 earnings as Medicaid payments drop; shares slide

HCA Healthcare forecasted flat 2027 earnings, citing lower Medicaid payments and rising uninsured patients, causing shares to drop over 5%. CEO Sam Hazen attributed the outlook to a fluid policy environment. Analysts expect 2027 EPS of $32.14, below the company's implied guidance. HCA's Q3 adjusted profit was $7.22 per share on revenue of $19.85 billion, beating estimates. The company expects 2026 EPS between $28.70 and $30.50 on revenue of $77.0B-$79.5B.

finance.yahoo.com2 min
OCT 27
$HCAMedAI 8/10

HCA Healthcare, Inc. Q3 2026 Earnings Call Summary

HCA Healthcare reported Q3 2026 volume growth of 3%, driven by demand across various service lines. The company offset payer mix pressure through higher revenue per admission and improved contract collections. Elective surgical volumes faced challenges due to federal policy changes. HCA maintained flat same-facility costs despite inflation. The company anticipates 2027 earnings to be generally consistent with 2026, with 2% to 3% volume growth.

finance.yahoo.com2 min